nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0494	0.126	CbGbCtD
Indapamide—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0464	0.119	CbGbCtD
Indapamide—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0464	0.119	CbGbCtD
Indapamide—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.042	0.107	CbGbCtD
Indapamide—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.042	0.107	CbGbCtD
Indapamide—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0362	0.0925	CbGbCtD
Indapamide—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0352	0.0898	CbGbCtD
Indapamide—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0318	0.0812	CbGbCtD
Indapamide—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0318	0.0812	CbGbCtD
Indapamide—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0305	0.0779	CbGbCtD
Indapamide—KCNE1—blood—acquired immunodeficiency syndrome	0.00602	0.0653	CbGeAlD
Indapamide—KCNE1—lung—acquired immunodeficiency syndrome	0.00528	0.0572	CbGeAlD
Indapamide—KCNE1—nervous system—acquired immunodeficiency syndrome	0.00489	0.053	CbGeAlD
Indapamide—CA4—nerve—acquired immunodeficiency syndrome	0.00441	0.0478	CbGeAlD
Indapamide—CA7—digestive system—acquired immunodeficiency syndrome	0.00319	0.0345	CbGeAlD
Indapamide—KCNQ1—digestive system—acquired immunodeficiency syndrome	0.0029	0.0315	CbGeAlD
Indapamide—CA9—digestive system—acquired immunodeficiency syndrome	0.0028	0.0303	CbGeAlD
Indapamide—KCNQ1—blood—acquired immunodeficiency syndrome	0.00277	0.03	CbGeAlD
Indapamide—CA2—blood plasma—acquired immunodeficiency syndrome	0.00276	0.03	CbGeAlD
Indapamide—KCNQ1—bone marrow—acquired immunodeficiency syndrome	0.00268	0.029	CbGeAlD
Indapamide—SLC12A3—lung—acquired immunodeficiency syndrome	0.00261	0.0283	CbGeAlD
Indapamide—KCNQ1—lung—acquired immunodeficiency syndrome	0.00242	0.0263	CbGeAlD
Indapamide—CA12—digestive system—acquired immunodeficiency syndrome	0.00207	0.0224	CbGeAlD
Indapamide—CA7—brain—acquired immunodeficiency syndrome	0.00188	0.0204	CbGeAlD
Indapamide—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00178	0.0193	CbGeAlD
Indapamide—CA5B—blood—acquired immunodeficiency syndrome	0.00177	0.0192	CbGeAlD
Indapamide—CA12—lung—acquired immunodeficiency syndrome	0.00173	0.0187	CbGeAlD
Indapamide—KCNQ1—brain—acquired immunodeficiency syndrome	0.00172	0.0186	CbGeAlD
Indapamide—KCNQ1—lymph node—acquired immunodeficiency syndrome	0.00166	0.018	CbGeAlD
Indapamide—CA5B—vagina—acquired immunodeficiency syndrome	0.00164	0.0178	CbGeAlD
Indapamide—CA12—nervous system—acquired immunodeficiency syndrome	0.0016	0.0174	CbGeAlD
Indapamide—CA5B—lung—acquired immunodeficiency syndrome	0.00155	0.0168	CbGeAlD
Indapamide—CA12—central nervous system—acquired immunodeficiency syndrome	0.00154	0.0167	CbGeAlD
Indapamide—CA2—retina—acquired immunodeficiency syndrome	0.00151	0.0164	CbGeAlD
Indapamide—CA5B—nervous system—acquired immunodeficiency syndrome	0.00144	0.0156	CbGeAlD
Indapamide—CA5B—central nervous system—acquired immunodeficiency syndrome	0.00138	0.015	CbGeAlD
Indapamide—Furosemide—ALB—acquired immunodeficiency syndrome	0.00137	0.624	CrCbGaD
Indapamide—CA2—skin of body—acquired immunodeficiency syndrome	0.00133	0.0144	CbGeAlD
Indapamide—CA4—digestive system—acquired immunodeficiency syndrome	0.00128	0.0139	CbGeAlD
Indapamide—CA12—brain—acquired immunodeficiency syndrome	0.00122	0.0133	CbGeAlD
Indapamide—CA4—blood—acquired immunodeficiency syndrome	0.00122	0.0132	CbGeAlD
Indapamide—CA4—bone marrow—acquired immunodeficiency syndrome	0.00118	0.0128	CbGeAlD
Indapamide—CA4—spinal cord—acquired immunodeficiency syndrome	0.00118	0.0128	CbGeAlD
Indapamide—CA5B—brain—acquired immunodeficiency syndrome	0.0011	0.0119	CbGeAlD
Indapamide—CA2—lymphoid tissue—acquired immunodeficiency syndrome	0.00108	0.0117	CbGeAlD
Indapamide—CA4—lung—acquired immunodeficiency syndrome	0.00107	0.0116	CbGeAlD
Indapamide—CA2—digestive system—acquired immunodeficiency syndrome	0.00106	0.0115	CbGeAlD
Indapamide—CA5B—lymph node—acquired immunodeficiency syndrome	0.00106	0.0115	CbGeAlD
Indapamide—CA2—blood—acquired immunodeficiency syndrome	0.00101	0.011	CbGeAlD
Indapamide—CA4—nervous system—acquired immunodeficiency syndrome	0.000991	0.0107	CbGeAlD
Indapamide—CA2—bone marrow—acquired immunodeficiency syndrome	0.00098	0.0106	CbGeAlD
Indapamide—CA2—spinal cord—acquired immunodeficiency syndrome	0.000976	0.0106	CbGeAlD
Indapamide—CA4—central nervous system—acquired immunodeficiency syndrome	0.000955	0.0103	CbGeAlD
Indapamide—CA2—vagina—acquired immunodeficiency syndrome	0.000939	0.0102	CbGeAlD
Indapamide—CA2—lung—acquired immunodeficiency syndrome	0.000888	0.00962	CbGeAlD
Indapamide—Oxcarbazepine—ALB—acquired immunodeficiency syndrome	0.000826	0.376	CrCbGaD
Indapamide—CA2—nervous system—acquired immunodeficiency syndrome	0.000822	0.00891	CbGeAlD
Indapamide—CA2—central nervous system—acquired immunodeficiency syndrome	0.000791	0.00858	CbGeAlD
Indapamide—CA4—brain—acquired immunodeficiency syndrome	0.000758	0.00821	CbGeAlD
Indapamide—CA4—lymph node—acquired immunodeficiency syndrome	0.000732	0.00794	CbGeAlD
Indapamide—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000686	0.00743	CbGeAlD
Indapamide—CYP3A4—blood—acquired immunodeficiency syndrome	0.000653	0.00708	CbGeAlD
Indapamide—CA2—brain—acquired immunodeficiency syndrome	0.000628	0.00681	CbGeAlD
Indapamide—CA2—lymph node—acquired immunodeficiency syndrome	0.000607	0.00658	CbGeAlD
Indapamide—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.00053	0.00575	CbGeAlD
Indapamide—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000511	0.00554	CbGeAlD
Indapamide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.00047	CcSEcCtD
Indapamide—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.00047	CcSEcCtD
Indapamide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000241	0.000469	CcSEcCtD
Indapamide—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000241	0.000469	CcSEcCtD
Indapamide—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.000469	CcSEcCtD
Indapamide—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.00024	0.000467	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00024	0.000467	CcSEcCtD
Indapamide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000239	0.000466	CcSEcCtD
Indapamide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000239	0.000465	CcSEcCtD
Indapamide—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000239	0.000465	CcSEcCtD
Indapamide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000239	0.000465	CcSEcCtD
Indapamide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000239	0.000465	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000239	0.000464	CcSEcCtD
Indapamide—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000239	0.000464	CcSEcCtD
Indapamide—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000238	0.000464	CcSEcCtD
Indapamide—Pain—Indinavir—acquired immunodeficiency syndrome	0.000237	0.000461	CcSEcCtD
Indapamide—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000237	0.000461	CcSEcCtD
Indapamide—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000237	0.000461	CcSEcCtD
Indapamide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000237	0.000461	CcSEcCtD
Indapamide—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000236	0.00046	CcSEcCtD
Indapamide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000236	0.000459	CcSEcCtD
Indapamide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000236	0.000459	CcSEcCtD
Indapamide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000235	0.000458	CcSEcCtD
Indapamide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000235	0.000458	CcSEcCtD
Indapamide—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000235	0.000458	CcSEcCtD
Indapamide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000235	0.000457	CcSEcCtD
Indapamide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000235	0.000457	CcSEcCtD
Indapamide—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000234	0.000456	CcSEcCtD
Indapamide—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000234	0.000456	CcSEcCtD
Indapamide—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000234	0.000455	CcSEcCtD
Indapamide—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000234	0.000454	CcSEcCtD
Indapamide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000233	0.000454	CcSEcCtD
Indapamide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000233	0.000453	CcSEcCtD
Indapamide—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.000453	CcSEcCtD
Indapamide—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.000453	CcSEcCtD
Indapamide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.000453	CcSEcCtD
Indapamide—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.000451	CcSEcCtD
Indapamide—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.000451	CcSEcCtD
Indapamide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000231	0.00045	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.00045	CcSEcCtD
Indapamide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000231	0.000449	CcSEcCtD
Indapamide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00023	0.000447	CcSEcCtD
Indapamide—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000229	0.000446	CcSEcCtD
Indapamide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000228	0.000445	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000228	0.000444	CcSEcCtD
Indapamide—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.000444	CcSEcCtD
Indapamide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000228	0.000443	CcSEcCtD
Indapamide—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000228	0.000443	CcSEcCtD
Indapamide—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000228	0.000443	CcSEcCtD
Indapamide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000227	0.000443	CcSEcCtD
Indapamide—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000227	0.000442	CcSEcCtD
Indapamide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000227	0.000442	CcSEcCtD
Indapamide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000227	0.000441	CcSEcCtD
Indapamide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000227	0.000441	CcSEcCtD
Indapamide—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000227	0.000441	CcSEcCtD
Indapamide—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.00044	CcSEcCtD
Indapamide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000226	0.00044	CcSEcCtD
Indapamide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000226	0.000439	CcSEcCtD
Indapamide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000226	0.000439	CcSEcCtD
Indapamide—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000225	0.000438	CcSEcCtD
Indapamide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000225	0.000438	CcSEcCtD
Indapamide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.000436	CcSEcCtD
Indapamide—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000224	0.000436	CcSEcCtD
Indapamide—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000224	0.000436	CcSEcCtD
Indapamide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000224	0.000436	CcSEcCtD
Indapamide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000224	0.000435	CcSEcCtD
Indapamide—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000223	0.000435	CcSEcCtD
Indapamide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000223	0.000435	CcSEcCtD
Indapamide—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000223	0.000434	CcSEcCtD
Indapamide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000223	0.000434	CcSEcCtD
Indapamide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000223	0.000433	CcSEcCtD
Indapamide—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.000432	CcSEcCtD
Indapamide—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.000432	CcSEcCtD
Indapamide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.000432	CcSEcCtD
Indapamide—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.000431	CcSEcCtD
Indapamide—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.00043	CcSEcCtD
Indapamide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000221	0.00043	CcSEcCtD
Indapamide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000221	0.000429	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.000429	CcSEcCtD
Indapamide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00022	0.000429	CcSEcCtD
Indapamide—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.000427	CcSEcCtD
Indapamide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000219	0.000427	CcSEcCtD
Indapamide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000219	0.000426	CcSEcCtD
Indapamide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000219	0.000426	CcSEcCtD
Indapamide—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.000426	CcSEcCtD
Indapamide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000219	0.000426	CcSEcCtD
Indapamide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000218	0.000425	CcSEcCtD
Indapamide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000218	0.000424	CcSEcCtD
Indapamide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000218	0.000424	CcSEcCtD
Indapamide—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000217	0.000422	CcSEcCtD
Indapamide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000217	0.000422	CcSEcCtD
Indapamide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000217	0.000422	CcSEcCtD
Indapamide—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.000422	CcSEcCtD
Indapamide—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.000421	CcSEcCtD
Indapamide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000216	0.000421	CcSEcCtD
Indapamide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000216	0.000421	CcSEcCtD
Indapamide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000216	0.00042	CcSEcCtD
Indapamide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000216	0.00042	CcSEcCtD
Indapamide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000216	0.00042	CcSEcCtD
Indapamide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.00042	CcSEcCtD
Indapamide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000216	0.000419	CcSEcCtD
Indapamide—Headache—Stavudine—acquired immunodeficiency syndrome	0.000215	0.000418	CcSEcCtD
Indapamide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000215	0.000418	CcSEcCtD
Indapamide—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000214	0.000417	CcSEcCtD
Indapamide—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000214	0.000417	CcSEcCtD
Indapamide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000214	0.000417	CcSEcCtD
Indapamide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000214	0.000416	CcSEcCtD
Indapamide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000213	0.000415	CcSEcCtD
Indapamide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000213	0.000414	CcSEcCtD
Indapamide—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.000414	CcSEcCtD
Indapamide—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.000414	CcSEcCtD
Indapamide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.000414	CcSEcCtD
Indapamide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000212	0.000412	CcSEcCtD
Indapamide—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.000411	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.000411	CcSEcCtD
Indapamide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000211	0.000411	CcSEcCtD
Indapamide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000211	0.00041	CcSEcCtD
Indapamide—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.000408	CcSEcCtD
Indapamide—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.000407	CcSEcCtD
Indapamide—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.000406	CcSEcCtD
Indapamide—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.000406	CcSEcCtD
Indapamide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.000405	CcSEcCtD
Indapamide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.000405	CcSEcCtD
Indapamide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.000405	CcSEcCtD
Indapamide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000207	0.000403	CcSEcCtD
Indapamide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000207	0.000403	CcSEcCtD
Indapamide—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.000402	CcSEcCtD
Indapamide—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000207	0.000402	CcSEcCtD
Indapamide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000207	0.000402	CcSEcCtD
Indapamide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.000401	CcSEcCtD
Indapamide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.0004	CcSEcCtD
Indapamide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000205	0.000399	CcSEcCtD
Indapamide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000204	0.000398	CcSEcCtD
Indapamide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000204	0.000397	CcSEcCtD
Indapamide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.000397	CcSEcCtD
Indapamide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000204	0.000397	CcSEcCtD
Indapamide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000204	0.000396	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.000395	CcSEcCtD
Indapamide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.000395	CcSEcCtD
Indapamide—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.000393	CcSEcCtD
Indapamide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.000392	CcSEcCtD
Indapamide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000201	0.000391	CcSEcCtD
Indapamide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.00039	CcSEcCtD
Indapamide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.0002	0.000389	CcSEcCtD
Indapamide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.0002	0.000389	CcSEcCtD
Indapamide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.000387	CcSEcCtD
Indapamide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000199	0.000387	CcSEcCtD
Indapamide—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.000387	CcSEcCtD
Indapamide—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.000387	CcSEcCtD
Indapamide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.000386	CcSEcCtD
Indapamide—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.000386	CcSEcCtD
Indapamide—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.000386	CcSEcCtD
Indapamide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000198	0.000386	CcSEcCtD
Indapamide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000198	0.000386	CcSEcCtD
Indapamide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000197	0.000384	CcSEcCtD
Indapamide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.000382	CcSEcCtD
Indapamide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000196	0.000382	CcSEcCtD
Indapamide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.000377	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.000377	CcSEcCtD
Indapamide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000193	0.000376	CcSEcCtD
Indapamide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.000375	CcSEcCtD
Indapamide—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000375	CcSEcCtD
Indapamide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.000374	CcSEcCtD
Indapamide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.000372	CcSEcCtD
Indapamide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000191	0.000372	CcSEcCtD
Indapamide—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.000371	CcSEcCtD
Indapamide—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.000371	CcSEcCtD
Indapamide—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.000369	CcSEcCtD
Indapamide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00019	0.000369	CcSEcCtD
Indapamide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00019	0.000369	CcSEcCtD
Indapamide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00019	0.000369	CcSEcCtD
Indapamide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.000368	CcSEcCtD
Indapamide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000188	0.000366	CcSEcCtD
Indapamide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000188	0.000366	CcSEcCtD
Indapamide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000188	0.000365	CcSEcCtD
Indapamide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000365	CcSEcCtD
Indapamide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000187	0.000363	CcSEcCtD
Indapamide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000185	0.000361	CcSEcCtD
Indapamide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.00036	CcSEcCtD
Indapamide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000185	0.000359	CcSEcCtD
Indapamide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.000358	CcSEcCtD
Indapamide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.000358	CcSEcCtD
Indapamide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.000357	CcSEcCtD
Indapamide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.000357	CcSEcCtD
Indapamide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000183	0.000357	CcSEcCtD
Indapamide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.000357	CcSEcCtD
Indapamide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.000357	CcSEcCtD
Indapamide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000182	0.000355	CcSEcCtD
Indapamide—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000354	CcSEcCtD
Indapamide—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000354	CcSEcCtD
Indapamide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00018	0.00035	CcSEcCtD
Indapamide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000179	0.000349	CcSEcCtD
Indapamide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000177	0.000345	CcSEcCtD
Indapamide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000345	CcSEcCtD
Indapamide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000177	0.000345	CcSEcCtD
Indapamide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.000343	CcSEcCtD
Indapamide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.000343	CcSEcCtD
Indapamide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000176	0.000343	CcSEcCtD
Indapamide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000175	0.000341	CcSEcCtD
Indapamide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000175	0.00034	CcSEcCtD
Indapamide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000175	0.00034	CcSEcCtD
Indapamide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000174	0.000339	CcSEcCtD
Indapamide—Headache—Indinavir—acquired immunodeficiency syndrome	0.000174	0.000338	CcSEcCtD
Indapamide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000173	0.000337	CcSEcCtD
Indapamide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000171	0.000334	CcSEcCtD
Indapamide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.000332	CcSEcCtD
Indapamide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000329	CcSEcCtD
Indapamide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.000327	CcSEcCtD
Indapamide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.000327	CcSEcCtD
Indapamide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000167	0.000324	CcSEcCtD
Indapamide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.000324	CcSEcCtD
Indapamide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000166	0.000322	CcSEcCtD
Indapamide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000165	0.000321	CcSEcCtD
Indapamide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000165	0.000321	CcSEcCtD
Indapamide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000165	0.00032	CcSEcCtD
Indapamide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.00032	CcSEcCtD
Indapamide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000164	0.000319	CcSEcCtD
Indapamide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000164	0.000319	CcSEcCtD
Indapamide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000311	CcSEcCtD
Indapamide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000159	0.00031	CcSEcCtD
Indapamide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000309	CcSEcCtD
Indapamide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.000307	CcSEcCtD
Indapamide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.000307	CcSEcCtD
Indapamide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000158	0.000307	CcSEcCtD
Indapamide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000157	0.000306	CcSEcCtD
Indapamide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.000305	CcSEcCtD
Indapamide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000156	0.000303	CcSEcCtD
Indapamide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000298	CcSEcCtD
Indapamide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000297	CcSEcCtD
Indapamide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000297	CcSEcCtD
Indapamide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.000293	CcSEcCtD
Indapamide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000149	0.00029	CcSEcCtD
Indapamide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.000287	CcSEcCtD
Indapamide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000287	CcSEcCtD
Indapamide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.000284	CcSEcCtD
Indapamide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.000284	CcSEcCtD
Indapamide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000283	CcSEcCtD
Indapamide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.000283	CcSEcCtD
Indapamide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000276	CcSEcCtD
Indapamide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000274	CcSEcCtD
Indapamide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.000274	CcSEcCtD
Indapamide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.000273	CcSEcCtD
Indapamide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000272	CcSEcCtD
Indapamide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000138	0.000268	CcSEcCtD
Indapamide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000263	CcSEcCtD
Indapamide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000261	CcSEcCtD
Indapamide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000261	CcSEcCtD
Indapamide—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000259	CcSEcCtD
Indapamide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000258	CcSEcCtD
Indapamide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000246	CcSEcCtD
